- Home
- CNTX vs TAYD Comparison
CNTX vs TAYD Comparison
Compare CNTX & TAYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- TAYD
- Stock Information
- Founded
- CNTX 2015
- TAYD 1955
- Country
- CNTX United States
- TAYD United States
- Employees
- CNTX N/A
- TAYD N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- TAYD Industrial Machinery/Components
- Sector
- CNTX Health Care
- TAYD Industrials
- Exchange
- CNTX Nasdaq
- TAYD Nasdaq
- Market Cap
- CNTX 149.6M
- TAYD 150.7M
- IPO Year
- CNTX 2021
- TAYD N/A
- Fundamental
- Price
- CNTX $1.30
- TAYD $46.34
- Analyst Decision
- CNTX Strong Buy
- TAYD
- Analyst Count
- CNTX 3
- TAYD 0
- Target Price
- CNTX $6.83
- TAYD N/A
- AVG Volume (30 Days)
- CNTX 210.1K
- TAYD 25.6K
- Earning Date
- CNTX 11-06-2024
- TAYD 01-08-2025
- Dividend Yield
- CNTX N/A
- TAYD N/A
- EPS Growth
- CNTX N/A
- TAYD 44.55
- EPS
- CNTX N/A
- TAYD 2.90
- Revenue
- CNTX N/A
- TAYD $46,277,035.00
- Revenue This Year
- CNTX N/A
- TAYD N/A
- Revenue Next Year
- CNTX N/A
- TAYD N/A
- P/E Ratio
- CNTX N/A
- TAYD $15.31
- Revenue Growth
- CNTX N/A
- TAYD 12.78
- 52 Week Low
- CNTX $0.77
- TAYD $21.99
- 52 Week High
- CNTX $2.75
- TAYD $64.50
- Technical
- Relative Strength Index (RSI)
- CNTX 25.94
- TAYD 49.69
- Support Level
- CNTX $1.56
- TAYD $43.50
- Resistance Level
- CNTX $2.32
- TAYD $45.23
- Average True Range (ATR)
- CNTX 0.16
- TAYD 3.25
- MACD
- CNTX -0.07
- TAYD 0.03
- Stochastic Oscillator
- CNTX 17.88
- TAYD 30.42
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 ("CLDN6") x anti-CD3 bispecific antibody ("bsAb") that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About TAYD Taylor Devices Inc.
Taylor Devices Inc is involved in the design, development, manufacture, and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment, and structures. The company's product line includes Seismic dampers, Fluidicshoks, Crane and industrial buffers, Self-adjusting shock absorbers, Liquid die springs, and Vibration Dampers. Its products are generally used to absorb, control, or mitigate the motion of masses caused by earthquakes or explosions. The company markets its products to various industries such as industrial, steel mills, buildings, bridges, aerospace, defense, and automotive industries.